AWP class action proceeds
Executive Summary
AWP proposed class action will proceed against all defendants except Roche under a Boston federal judge's ruling. Judge Patti Saris declined to dismiss plaintiffs' claims that drug manufacturers and pharmacy benefit managers - who are not defendants in the case - engaged in racketeering with the objective of promoting fraudulent AWPs, and that manufacturers in the Together Rx discount drug card program engaged in a price-fixing conspiracy. The Together Rx allegations were included in an amended class action complaint in July (1"The Pink Sheet" Aug. 18, 2003, p. 11)...
You may also be interested in...
Together Rx Cited In AWP Price-Fixing Suit; Amended Complaint Drops Merck
A class action suit alleges manufacturers participating in the Together Rx discount drug card program are involved in a conspiracy to increase the average wholesale price "spread" on products in the program
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.